Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10633 - 10640 of 11616 results
Equal Pay Act: Male employee's strong negotiating skills not a "factor other than sex" to justify pay differential
June 18, 2013| Blog| Viewpoint
More About Trademark Surnames: The Borghese Dispute
June 17, 2013| Blog| Viewpoint
DOE Releases New Protocols to Determine Energy Efficiency Savings
June 17, 2013| Article| Viewpoint
ML Strategies Posts Weekly Health Care Reform Update on June 17, 2013
June 17, 2013| Blog| Viewpoint
Financial Innovation for Clean Energy Deployment: Congress Considers Expanding Master Limited Partnerships for Clean Energy
June 14, 2013| Article| Viewpoint
Solar PV Capacity Quickly Expands When States Provide the Right Incentives
June 14, 2013| Article| Viewpoint
SiNode Systems Takes Home the National Clean Energy Business Competition Prize
June 13, 2013| Blog| Viewpoint
Examining Charitable Patient Assistance Programs: Careful Due Diligence Yields Responsible Investment Decisions
June 13, 2013| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.